Oramed Pharmaceuticals (ORMP) Cash from Operations (2010 - 2026)
Oramed Pharmaceuticals (ORMP) posted Cash from Operations of 2915000.0 for Q1 2026, down 525.54% on a QoQ basis from 466000.0 in Q4 2025, and up 17.16% year-over-year from 2487966.29 in Q1 2025.
Oramed Pharmaceuticals (ORMP) Cash from Operations (2010 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Cash from Operations history runs 17 years deep, the most recent figure standing at 2915000.0 for Q1 2026.
- Quarterly Cash from Operations rose 17.16% year-over-year to 2915000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8541000.0 (up 18.31% YoY) and the FY2025 annual result came in at 9145000.0, down 8.71% from the prior year.
- Cash from Operations was 2915000.0 for Q1 2026 at Oramed Pharmaceuticals, down from 466000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 2076000.0 in Q2 2024 and bottomed at 9125000.0 in Q1 2022.
- A 5-year average of 3452058.82 and a median of 2634000.0 in 2023 frame the typical range for Cash from Operations.
- Peak annual rise in Cash from Operations reached 178.82% in 2024, while the deepest fall reached 923.2% in 2024.
- Oramed Pharmaceuticals' Cash from Operations stood at 8062000.0 in 2022, then surged by 82.41% to 1418000.0 in 2023, then sank by 34.77% to 1911000.0 in 2024, then jumped by 75.61% to 466000.0 in 2025, then plunged by 525.54% to 2915000.0 in 2026.
- Business Quant data shows ORMP's Cash from Operations at 2915000.0 in Q1 2026, 466000.0 in Q4 2025, and 1625000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | -2.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.92 Mn |
| Mar 31, 2026 | -2.92 Mn |
| Dec 31, 2025 | -466,000.00 |
| Dec 31, 2025 | -466,000.00 |
| Sep 30, 2025 | -1.63 Mn |
| Sep 30, 2025 | -1.63 Mn |
| Jun 30, 2025 | -3.54 Mn |
| Jun 30, 2025 | -3.54 Mn |
| Mar 31, 2025 | -3.52 Mn |
| Mar 31, 2025 | -3.52 Mn |
| Dec 31, 2024 | -1.91 Mn |
| Dec 31, 2024 | -1.91 Mn |
| Sep 30, 2024 | -7.10 Mn |
| Sep 30, 2024 | -7.10 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Mar 31, 2024 | -1.48 Mn |
| Mar 31, 2024 | -1.48 Mn |
| Dec 31, 2023 | -1.42 Mn |
| Dec 31, 2023 | -1.42 Mn |